ErbB Signaling Is Required for the Proliferative Actions of GLP-2 in the Murine Gut

Gastroenterology

Volumn 137, Issue 3, 2009, Pages 986-996

  Yusta, Bernardo ^a   Holland, Dianne ^a   Koehler, Jacqueline A ^a   Maziarz, Marlena ^a   Estall, Jennifer L ^a   Higgins, Rachel ^a   Drucker, Daniel J ^a  

^a MOUNT SINAI HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHIREGULIN; CANERTINIB; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIREGULIN; GLUCAGON LIKE PEPTIDE 2; HEPARIN BINDING EPIDERMAL GROWTH FACTOR; KERATINOCYTE GROWTH FACTOR; METALLOPROTEINASE INHIBITOR; SOMATOMEDIN C;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; CRYPT CELL; FEMALE; GENE EXPRESSION; GROWTH CURVE; IMMEDIATE EARLY GENE; IMMUNOHISTOCHEMISTRY; LARGE INTESTINE; MORPHOMETRICS; MOUSE; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL; SMALL INTESTINE; WESTERN BLOTTING;

EID: 69249138379     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2009.05.057     Document Type: Article

References (36)

1. Drucker D.J. The biology of incretin hormones. Cell Metab 3 (2006) 153-165
2. Buteau J., Foisy S., Joly E., et al. Glucagon-like peptide 1 induces pancreatic β-cell proliferation via transactivation of the epidermal growth factor receptor. Diabetes 52 (2003) 124-132
3. Munroe D.G., Gupta A.K., Kooshesh F., et al. Prototypic G protein-coupled receptor for the intestinotrophic factor glucagon-like peptide 2. Proc Natl Acad Sci U S A 96 (1999) 1569-1573
4. Mayo K.E., Miller L.J., Bataille D., et al. International Union of Pharmacology. XXXV. The glucagon receptor family. Pharmacol Rev 55 (2003) 167-194
5. Yusta B., Estall J., and Drucker D.J. GLP-2 receptor activation engages Bad and glycogen synthase kinase 3 in a protein kinase A-dependent manner and prevents apoptosis following inhibition of phosphatidylinositol 3-kinase. J Biol Chem 277 (2002) 24896-24906
6. Burrin D.G., Stoll B., Guan X., et al. Glucagon-like peptide 2 dose-dependently activates intestinal cell survival and proliferation in neonatal piglets. Endocrinology 146 (2005) 22-32
7. Bjerknes M., and Cheng H. Modulation of specific intestinal epithelial progenitors by enteric neurons. Proc Natl Acad Sci U S A 98 (2001) 12497-12502
8. Guan X., Karpen H.E., Stephens J., et al. GLP-2 receptor localizes to enteric neurons and endocrine cells expressing vasoactive peptides and mediates increased blood flow. Gastroenterology 130 (2006) 150-164
9. Nelson D.W., Sharp J.W., Brownfield M.S., et al. Localization and activation of glucagon-like peptide-2 receptors on vagal afferents in the rat. Endocrinology 148 (2007) 1954-1962
10. Yusta B., Huang L., Munroe D., et al. Enteroendocrine localization of GLP-2 receptor expression. Gastroenterology 119 (2000) 744-755
11. Orskov C., Hartmann B., Poulsen S.S., et al. GLP-2 stimulates colonic growth via KGF, released by subepithelial myofibroblasts with GLP-2 receptors. Regul Pept 124 (2005) 105-112
12. Sigalet D.L., Wallace L.E., Holst J.J., et al. Enteric neural pathways mediate the anti-inflammatory actions of glucagon-like peptide 2. Am J Physiol Gastrointest Liver Physiol 293 (2007) G211-G221
13. Guan X., Stoll B., Lu X., et al. GLP-2-mediated up-regulation of intestinal blood flow and glucose uptake is nitric oxide-dependent in TPN-fed piglets 1. Gastroenterology 125 (2003) 136-147
14. Dube P.E., Forse C.L., Bahrami J., et al. The essential role of insulin-like growth factor-1 in the intestinal tropic effects of glucagon-like peptide-2 in mice. Gastroenterology 131 (2006) 589-605
15. Dube P.E., Rowland K.J., and Brubaker P.L. Glucagon-like peptide-2 activates β-catenin signaling in the mouse intestinal crypt: role of insulin-like growth factor-I. Endocrinology 149 (2008) 291-301
16. Walters J.R. Cell and molecular biology of the small intestine: new insights into differentiation, growth and repair. Curr Opin Gastroenterol 20 (2004) 70-76
17. Koehler J.A., Harper W., Barnard M., et al. Glucagon-like peptide-2 does not modify the growth or survival of murine or human intestinal tumor cells. Cancer Res 68 (2008) 7897-7904
18. Luetteke N.C., Phillips H.K., Qiu T.H., et al. The mouse waved-2 phenotype results from a point mutation in the EGF receptor tyrosine kinase. Genes Dev 8 (1994) 399-413
19. Christensen J.G., Vincent P.W., Klohs W.D., et al. Plasma vascular endothelial growth factor and interleukin-8 as biomarkers of antitumor efficacy of a prototypical erbB family tyrosine kinase inhibitor. Mol Cancer Ther 4 (2005) 938-947
20. Nyati M.K., Maheshwari D., Hanasoge S., et al. Radiosensitization by pan ErbB inhibitor CI-1033 in vitro and in vivo. Clin Cancer Res 10 (2004) 691-700
21. Koehler J.A., Yusta B., and Drucker D.J. The HeLa cell glucagon-like peptide-2 receptor is coupled to regulation of apoptosis and ERK1/2 activation through divergent signaling pathways. Mol Endocrinol 19 (2005) 459-473
22. Nowak M., Gaines G.C., Rosenberg J., et al. LPS-induced liver injury in D-galactosamine-sensitized mice requires secreted TNF-α and the TNF-p55 receptor. Am J Physiol Regul Integr Comp Physiol 278 (2000) R1202-R1209
23. Solorzano C.C., Ksontini R., Pruitt J.H., et al. Involvement of 26-kDa cell-associated TNF-α in experimental hepatitis and exacerbation of liver injury with a matrix metalloproteinase inhibitor. J Immunol 158 (1997) 414-419
24. Citri A., and Yarden Y. EGF-ERBB signalling: towards the systems level. Nat Rev Mol Cell Biol 7 (2006) 505-516
25. Helmrath M.A., Erwin C.R., and Warner B.W. A defective EGF-receptor in waved-2 mice attenuates intestinal adaptation. J Surg Res 69 (1997) 76-80
26. Warner B.W., and Erwin C.R. Critical roles for EGF receptor signaling during resection-induced intestinal adaptation. J Pediatr Gastroenterol Nutr 43 Suppl 1 (2006) S68-S73
27. Dahly E.M., Gillingham M.B., Guo Z., et al. Role of luminal nutrients and endogenous GLP-2 in intestinal adaptation to mid-small bowel resection. Am J Physiol Gastrointest Liver Physiol 284 (2003) G670-G682
28. Al-Nafussi A.I., and Wright N.A. The effect of epidermal growth factor (EGF) on cell proliferation of the gastrointestinal mucosa in rodents. Virchows Arch 40 (1982) 63-69
29. Drucker D.J., Ehrlich P., Asa S.L., et al. Induction of intestinal epithelial proliferation by glucagon-like peptide 2. Proc Natl Acad Sci U S A 93 (1996) 7911-7916
30. Chaet M.S., Arya G., Ziegler M.M., et al. Epidermal growth factor enhances intestinal adaptation after massive small bowel resection. J Pediatr Surg 29 (1994) 1035-1039
31. Scott R.B., Kirk D., MacNaughton W.K., et al. GLP-2 augments the adaptive response to massive intestinal resection in rat. Am J Physiol 275 (1998) G911-G921
32. Lee K.K., Jo H.J., Hong J.P., et al. Recombinant human epidermal growth factor accelerates recovery of mouse small intestinal mucosa after radiation damage. Int J Radiat Oncol Biol Phys 71 (2008) 1230-1235
33. Torres S., Thim L., Milliat F., et al. Glucagon-like peptide-2 improves both acute and late experimental radiation enteritis in the rat. Int J Radiat Oncol Biol Phys 69 (2007) 1563-1571
34. Drucker D.J., Yusta B., Boushey R.P., et al. Human [Gly2]-GLP-2 reduces the severity of colonic injury in a murine model of experimental colitis. Am J Physiol 276 (1999) G79-G91
35. Egger B., Carey H.V., Procaccino F., et al. Reduced susceptibility of mice overexpressing transforming growth factor α to dextran sodium sulphate colitis. Gut 43 (1998) 64-70
36. Ribbons K.A., Howarth G.S., Davey K.B., et al. Subcutaneous but not intraluminal epidermal growth factor stimulates colonic growth in normal adult rats. Growth Factors 10 (1994) 153-162